The use of attention-deficit hyperactivity disorder medications in cardiac disease.

Topriceanu, Constantin-Cristian; Moon, James C; Captur, Gabriella; Perera, Bhathika

Topriceanu, Constantin-Cristian; Moon, James C; Captur, Gabriella; Perera, Bhathika.

Afiliación

Topriceanu CC; Barnet, Enfield and Haringey Mental Health Trust, London, United Kingdom.
Moon JC; UCL Institute of Cardiovascular Science, University College London, London, United Kingdom.
Captur G; UCL MRC Unit for Lifelong Health and Ageing, University College London, London, United Kingdom.
Perera B; Cardiac MRI Unit, Barts Heart Centre, London, United Kingdom.

Front Neurosci ; 16: 1020961, 2022.

Article en En | MEDLINE | ID: mdl-36340760

Palabras clave

ADHD (attention deficit and hyperactivity disorder); aortopathies; blood pressure; cardiomyopathies; cardiovascular disease; electrocardiogram (ECG); non-stimulant medications for ADHD; stimulant medications for ADHD

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Aspecto: Patient_preference Idioma: En Revista: Front Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google